Skip to main content
. 2014 Dec 15;7(12):5041–5049.

Table 2.

RRM1 and hENT-1 expression association with chemotherapy response

Clinical outcomes after chemotherapy

Variables SD+PR PD P
G 5 (11.36%) 4 (9.10%)
G+FU/G+P 4 (9.10%)/16 (36.37%) 1 (2.27%)/14 (31.82%) 0.932
RRM1
    Negative 16 (36.37%) 6 (13.64%)
    Positive 9 (20.45%) 13 (29.55%) 0.033
hENT-1
    Negative 7 (15.91%) 11 (25.00%)
    Positive 18 (40.91%) 8 (18.18%) 0.046

G, gemcitabine; FU, 5-fluorouracil; P, cis-platinum; PR, partial response; SD, stable disease; PD, progression disease.